Search companies

Live

STARPHARMA HOLDINGS LIMITED (ASX: SPL)

Health care · News and insights

Price unavailable

Latest SPL announcements

Announcement Insights

Starpharma Changes Chair After 12 Years as Vested Rights Add Shares

Starpharma appointed Dr Russell Basser chair after the AGM, ending Rob Thomas’s 12-year tenure in the role; Thomas remains a non-executive director, and David McIntyre became deputy chair. Separately, about 3.2 million shares were issued on 30 October after employee performance rights vested, bringing the expected total to about 483 million shares following quotation.

Updated 06 Nov 2026, 03:37 PM Sydney time
Share
SourcesAGM Chair address and CEO presentationResults of 2026 Annual General MeetingChair and Deputy Chair AppointmentsBecoming a substantial holderApplication for quotation of securities - SPL
Comments

Starpharma Names New Chair as Rob Thomas Steps Down After 12 Years

2026-11-06 · Health care

SPL: $0.445 -3.26% · MC: $205M

Dr Russell Basser has become Starpharma’s chair and David McIntyre its deputy chair, following the AGM; Rob Thomas retired as chair after 12 years but will remain a non-executive director. The AGM also approved the resolutions put to shareholders, including the re-election of directors and the performance rights plan.

Updated 2026-11-06 15:30
Share
SourcesAGM Chair address and CEO presentationResults of 2026 Annual General MeetingChair and Deputy Chair Appointments
Comments